Dixon Mitchell Investment Counsel Inc. Has $31.63 Million Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Dixon Mitchell Investment Counsel increased its stake in HCA Healthcare by 3.1% in Q3 to 74,104 shares, a position valued at about $31.63 million.
• HCA reported quarterly EPS of $8.01 (beating estimates) with revenue of $19.51B (+6.7% YoY) and set FY2026 guidance of $29.10–$31.50 per share while analysts expect about $24.98 for the year.
• The company raised its quarterly dividend to $0.78 (from $0.72), implying an annualized payout of $3.12 and a roughly 0.6% yield.

Dixon Mitchell Investment Counsel Inc. raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 74,104 shares of the company's stock after acquiring an additional 2,261 shares during the period. Dixon Mitchell Investment Counsel Inc.'s holdings in HCA Healthcare were worth $31,627,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in HCA. Cerity Partners LLC grew its stake in shares of HCA Healthcare by 13.1% in the third quarter. Cerity Partners LLC now owns 43,920 shares of the company's stock valued at $18,719,000 after acquiring an additional 5,092 shares in the last quarter. Swiss National Bank grew its position in shares of HCA Healthcare by 4.3% during the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company's stock worth $214,115,000 after purchasing an additional 23,100 shares in the last quarter. National Pension Service raised its position in shares of HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company's stock valued at $267,051,000 after buying an additional 17,531 shares in the last quarter. Savant Capital LLC grew its position in HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company's stock worth $1,938,000 after buying an additional 1,246 shares in the last quarter. Finally, Sector Gamma AS raised its holdings in HCA Healthcare by 36.0% in the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company's stock valued at $4,638,000 after acquiring an additional 2,883 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $545.88 on Tuesday. HCA Healthcare, Inc. has a fifty-two week low of $310.18 and a fifty-two week high of $552.90. The firm has a market capitalization of $122.07 billion, a P/E ratio of 19.23, a P/E/G ratio of 1.64 and a beta of 1.34. The company's 50 day moving average price is $501.78 and its two-hundred day moving average price is $466.79.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts' consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare's payout ratio is 10.15%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the business's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the business's stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. This trade represents a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. Company insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on HCA shares. JPMorgan Chase & Co. raised their price target on HCA Healthcare from $420.00 to $535.00 and gave the stock a "neutral" rating in a research report on Friday, February 20th. Weiss Ratings reissued a "buy (b)" rating on shares of HCA Healthcare in a report on Monday, December 29th. Morgan Stanley lowered shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and set a $425.00 price target on the stock. in a research report on Monday, December 15th. UBS Group upped their target price on HCA Healthcare from $598.00 to $635.00 and gave the stock a "buy" rating in a research note on Monday, February 23rd. Finally, The Goldman Sachs Group boosted their price target on HCA Healthcare from $520.00 to $558.00 and gave the stock a "buy" rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $534.50.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.